Még nem toboroz
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
NCT07850063· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
NCT07567001· 3. fázis· Novo Nordisk A/S· Forrás
Contact: Novo Nordisk
Toboroz
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
NCT07365995· 3. fázis· BioNTech SE· Forrás
Toboroz
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
NCT07226843· 1. fázis· Eli Lilly and Company· Forrás
Toboroz
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
NCT07174336· 3. fázis· Eli Lilly and Company· Forrás
Contact: Udaiveer Panwar (principal investigator)
Toboroz
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
NCT07223593· 3. fázis· Eli Lilly and Company· Forrás
Contact: Devender Mittapalli (principal investigator)
Toboroz
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
NCT07028853· 3. fázis· Pfizer· Forrás
Toboroz
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
NCT06852222· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
NCT06876662· 4. fázis· Eli Lilly and Company· Forrás
Contact: David John Lewis (principal investigator)
Toboroz
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
NCT06876649· 4. fázis· Eli Lilly and Company· Forrás
Contact: David John Lewis (principal investigator)
Toboroz
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
NCT06644781· 3. fázis· Daiichi Sankyo· Forrás
Toboroz
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
NCT06742996· 3. fázis· BeOne Medicines· Forrás
Contact: Study Director
Fut, nem toboroz
Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
NCT05093231· 2. fázis· Cambridge University Hospitals NHS Foundation Trust· Forrás
Toboroz
Ambroxol to Slow Progression in Parkinson Disease
NCT05778617· 3. fázis· University College, London· Forrás
Contact: Stephen Mullin
Fut, nem toboroz
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)
NCT06635824· 3. fázis· Genmab· Forrás
Toboroz
A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
NCT06320067· 3. fázis· University College, London· Forrás
Contact: Pamela Niem
Fut, nem toboroz
A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
NCT06425991· 1. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
NCT05635162· 2. fázis· University College, London· Forrás
Contact: David Lewis
Fut, nem toboroz
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
NCT06225596· 2. fázis· BicycleTx Limited· Forrás
Fut, nem toboroz
Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma
NCT05004064· 2. fázis· University College, London· Forrás
Toboroz
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
NCT06084936· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
CGM Use in Adults With Type 2 Diabetes on Basal Insulin
NCT05944432· Abbott Diabetes Care· Forrás
Toboroz
A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
NCT06461208· 3. fázis· King's College London· Forrás
Contact: Matthew Cramp
Toboroz
RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure
NCT05568069· University Hospital Southampton NHS Foundation Trust· Forrás
Contact: Ben Sieniewicz, Dr
Fut, nem toboroz
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)
NCT05714202· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
NCT05677971· 3. fázis· Takeda· Forrás
Contact: Ashwin Dhanda (principal investigator)
Fut, nem toboroz
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
NCT05024773· 3. fázis· Fidia Farmaceutici s.p.a.· Forrás
Toboroz
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
NCT04685616· 3. fázis· University College, London· Forrás
Contact: Patrick Medd
Fut, nem toboroz
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
NCT05100862· 3. fázis· BeOne Medicines· Forrás
Toboroz
Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
NCT05604963· University College, London· Forrás
Contact: Richard Williams (principal investigator)
Fut, nem toboroz
Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)
NCT04546620· 2. fázis· University Hospital Southampton NHS Foundation Trust· Forrás
Fut, nem toboroz
A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
NCT04965493· 3. fázis· Loxo Oncology, Inc.· Forrás
Toboroz
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716· 1/2. fázis· BeOne Medicines· Forrás
Contact: BeOne Medicines
Toboroz
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
NCT04774159· 3. fázis· Population Health Research Institute· Forrás
Contact: Lisa Shainberg
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
NCT04777331· 2. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)
NCT04662255· 3. fázis· Loxo Oncology, Inc.· Forrás
Fut, nem toboroz
Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT04666038· 3. fázis· Loxo Oncology, Inc.· Forrás
Toboroz
Methods of T Cell Depletion Trial (MoTD)
NCT04888741· 2. fázis· University of Birmingham· Forrás
Contact: MoTD Trial
Fut, nem toboroz
A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
NCT04628494· 3. fázis· Genmab· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
NCT04548999· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
NCT04544436· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
NCT04663347· 1/2. fázis· Genmab· Forrás
Fut, nem toboroz
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
NCT04546009· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
NCT04307576· 3. fázis· Mats Heyman· Forrás
Contact: Hannah Hunter, M.D. (principal investigator)
Toboroz
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NCT04204915· University of Leicester· Forrás
Contact: Dr Sivasankar Sangaraju
Fut, nem toboroz
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
NCT04191499· 2/3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT
NCT04217278· 2/3. fázis· University of Birmingham· Forrás
Toboroz
MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera
NCT04116502· 3. fázis· University of Birmingham· Forrás
Contact: Natalia Morelli
Fut, nem toboroz
A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome
NCT03899337· 2. fázis· University of Birmingham· Forrás
Showing 50 of 61.